Journal article
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Abstract
BACKGROUND: More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
METHODS: We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of plasma exchange and two regimens of oral glucocorticoids in patients with severe ANCA-associated vasculitis (defined by an estimated glomerular filtration rate of <50 ml per minute per 1.73 m2 of body-surface area or diffuse …
Authors
Walsh M; Merkel PA; Peh C-A; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R
Journal
The New England Journal of Medicine, Vol. 382, No. 7, pp. 622–631
Publisher
Massachusetts Medical Society
Publication Date
February 13, 2020
DOI
10.1056/nejmoa1803537
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralAdultAgedAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisCombined Modality TherapyCyclophosphamideDose-Response Relationship, DrugFemaleGlucocorticoidsHumansImmunosuppressive AgentsIncidenceInduction ChemotherapyKidney DiseasesKidney Failure, ChronicMaleMiddle AgedPlasma ExchangeRituximab